HMGB1 and pulmonary hypertension: We also demonstrated that inhibition of HMGB1 by GLY treatment improved the survival rates of MCT-induced pulmonary hypertension rats by reducing pulmonary hypertension and attenuating pulmonary vascular remodeling and RV hypertrophy.